Mercers survey indicated that some employers chose to enhance key benefits by adding GLP-1 coverage even as overall health costs rose modestly ( [28] )
Semaglutide is a GLP-1 receptor agonist medication that is an active ingredient in medications (Ozempic and Wegovy) that helps regulate blood sugar levels, suppresses appetite, and promotes feelings of fullness
The efficacy of subcutaneous semaglutide was established in the phase III SUSTAIN program (SUSTAIN 15 and 7), in which significant reductions in mean glycated hemoglobin (HbA 1c ) and body weight were demonstrated against placebo and a variety of active comparators in multiple patient groups with T2D [26,27,28,29,30,31,32,33]
Are GLP-1 Medications Safe
For some people, the bodys incretin response the hormone signal released from the gut after eating does not function properly
When tirzepatide was in Phase 3 trials, similar silence preceded the KwikPen device announcement